{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:30:33Z","timestamp":1794274233889,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"crossref","award":["PDR T00075.15"],"award-info":[{"award-number":["PDR T00075.15"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"crossref","award":["PDR T0236.20"],"award-info":[{"award-number":["PDR T0236.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"crossref","award":["EOS 30913351"],"award-info":[{"award-number":["EOS 30913351"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016352","name":"Fondation JED","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016352","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022601","name":"Fondation M\u00e9dicale Reine Elisabeth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"DOI":"10.1007\/s00701-023-05544-3","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:03:04Z","timestamp":1678878184000},"page":"1075-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics"],"prefix":"10.1007","volume":"165","author":[{"given":"Georges","family":"Chehade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e9vi Morel","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lelotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Whenham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tajeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadel","family":"Tissir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9934-2024","authenticated-orcid":false,"given":"Christian","family":"Raftopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"5544_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1748-717X-9-95","volume":"9","author":"S Adeberg","year":"2014","unstructured":"Adeberg S, Bostel T, Konig L, Welzel T, Debus J, Combs SE (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95. https:\/\/doi.org\/10.1186\/1748-717X-9-95","journal-title":"Radiat Oncol"},{"key":"5544_CR2","doi-asserted-by":"publisher","first-page":"e0130596","DOI":"10.1371\/journal.pone.0130596","volume":"10","author":"A Amelot","year":"2015","unstructured":"Amelot A, De Cremoux P, Quillien V, Polivka M, Adle-Biassette H, Lehmann-Che J, Francoise L, Carpentier AF, George B, Mandonnet E, Froelich S (2015) IDH-mutation is a weak predictor of long-term survival in glioblastoma patients. PLoS One 10:e0130596. https:\/\/doi.org\/10.1371\/journal.pone.0130596","journal-title":"PLoS One"},{"key":"5544_CR3","doi-asserted-by":"publisher","unstructured":"Armocida D, Pesce A, Di Giammarco F, Frati A, Santoro A, Salvati M (2019) Long term survival in patients suffering from glio-blastoma multiforme: a single-center observational cohort study. Diagnostics (Basel) 9. https:\/\/doi.org\/10.3390\/diagnostics9040209","DOI":"10.3390\/diagnostics9040209"},{"key":"5544_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-012-1016-2","volume":"124","author":"P Bady","year":"2012","unstructured":"Bady P, Sciuscio D, Diserens AC, Bloch J, van den Bent MJ, Marosi C, Dietrich PY, Weller M, Mariani L, Heppner FL, McDonald DR, Lacombe D, Stupp R, Delorenzi M, Hegi ME (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol 124:547\u2013560. https:\/\/doi.org\/10.1007\/s00401-012-1016-2","journal-title":"Acta Neuropathol"},{"key":"5544_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/neuonc\/not159","volume":"16","author":"J Beiko","year":"2014","unstructured":"Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, Shonka N, Gilbert MR, Sawaya R, Prabhu SS, Weinberg J, Lang FF, Aldape KD, Sulman EP, Rao G, McCutcheon IE, Cahill DP (2014) IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 16:81\u201391. https:\/\/doi.org\/10.1093\/neuonc\/not159","journal-title":"Neuro Oncol"},{"key":"5544_CR6","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","volume":"34","author":"E Bouffet","year":"2016","unstructured":"Bouffet E, Larouche V, Campbell BB, Merico D, de Borja R, Aronson M, Durno C, Krueger J, Cabric V, Ramaswamy V, Zhukova N, Mason G, Farah R, Afzal S, Yalon M, Rechavi G, Magimairajan V, Walsh MF, Constantini S, Dvir R, Elhasid R, Reddy A, Osborn M, Sullivan M, Hansford J, Dodgshun A, Klauber-Demore N, Peterson L, Patel S, Lindhorst S, Atkinson J, Cohen Z, Laframboise R, Dirks P, Taylor M, Malkin D, Albrecht S, Dudley RW, Jabado N, Hawkins CE, Shlien A, Tabori U (2016) Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol 34:2206\u20132211. https:\/\/doi.org\/10.1200\/JCO.2016.66.6552","journal-title":"J Clin Oncol"},{"key":"5544_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-020-02127-9","volume":"139","author":"DJ Brat","year":"2020","unstructured":"Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Reifenberger G, Sarkar C, Stupp R, van den Bent MJ, von Deimling A, Weller M (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139:603\u2013608. https:\/\/doi.org\/10.1007\/s00401-020-02127-9","journal-title":"Acta Neuropathol"},{"key":"5544_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cdiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.\u201d Acta Neuropathol 136:805\u2013810. https:\/\/doi.org\/10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol"},{"key":"5544_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O\u2019Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, Network TR (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477. https:\/\/doi.org\/10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"key":"5544_CR10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.mayocp.2018.11.031","volume":"94","author":"JN Cantrell","year":"2019","unstructured":"Cantrell JN, Waddle MR, Rotman M, Peterson JL, Ruiz-Garcia H, Heckman MG, Quinones-Hinojosa A, Rosenfeld SS, Brown PD, Trifiletti DM (2019) Progress toward long-term survivors of glioblastoma. Mayo Clin Proc 94:1278\u20131286. https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.031","journal-title":"Mayo Clin Proc"},{"key":"5544_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Holsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Bruck W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hanggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Muhleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Muller HL, Rutkowski S, von Hoff K, Fruhwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blumcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schuller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"5544_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK, Huang K, Sievers P, Ebrahimi A, Scholer A, Teichmann D, Koch A, Hanggi D, Unterberg A, Platten M, Wick W, Witt O, Milde T, Korshunov A, Pfister SM, von Deimling A (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136:181\u2013210. https:\/\/doi.org\/10.1007\/s00401-018-1879-y","journal-title":"Acta Neuropathol"},{"key":"5544_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/neuonc\/nou097","volume":"16","author":"L Chen","year":"2014","unstructured":"Chen L, Voronovich Z, Clark K, Hands I, Mannas J, Walsh M, Nikiforova MN, Durbin EB, Weiss H, Horbinski C (2014) Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma. Neuro Oncol 16:1478\u20131483. https:\/\/doi.org\/10.1093\/neuonc\/nou097","journal-title":"Neuro Oncol"},{"key":"5544_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.23736\/S0390-5616.18.04180-2","volume":"63","author":"E Costa","year":"2019","unstructured":"Costa E, Lawson TM, Lelotte J, Fomekong E, Vaz RG, Renard L, Whenham N, Raftopoulos C (2019) Long-term survival after glioblastoma resection: hope despite poor prognosis factors. J Neurosurg Sci 63:251\u2013257. https:\/\/doi.org\/10.23736\/S0390-5616.18.04180-2","journal-title":"J Neurosurg Sci"},{"key":"5544_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac177","author":"R Drexler","year":"2022","unstructured":"Drexler R, Schuller U, Eckhardt A, Filipski K, Hartung TI, Harter PN, Dive I, Forster MT, Czabanka M, Jelgersma C, Onken J, Vajkoczy P, Capper D, Siewert C, Sauvigny T, Lamszus K, Westphal M, Duhrsen L, Ricklefs FL (2022) DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noac177","journal-title":"Neuro Oncol"},{"key":"5544_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/neuonc\/nov027","volume":"17","author":"EZ Erson-Omay","year":"2015","unstructured":"Erson-Omay EZ, Caglayan AO, Schultz N, Weinhold N, Omay SB, Ozduman K, Koksal Y, Li J, Serin Harmanci A, Clark V, Carrion-Grant G, Baranoski J, Caglar C, Barak T, Coskun S, Baran B, Kose D, Sun J, Bakircioglu M, Moliterno Gunel J, Pamir MN, Mishra-Gorur K, Bilguvar K, Yasuno K, Vortmeyer A, Huttner AJ, Sander C, Gunel M (2015) Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro Oncol 17:1356\u20131364. https:\/\/doi.org\/10.1093\/neuonc\/nov027","journal-title":"Neuro Oncol"},{"key":"5544_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ajco.12076","volume":"10","author":"KM Field","year":"2014","unstructured":"Field KM, Rosenthal MA, Yilmaz M, Tacey M, Drummond K (2014) Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset. Asia Pac J Clin Oncol 10:153\u2013161. https:\/\/doi.org\/10.1111\/ajco.12076","journal-title":"Asia Pac J Clin Oncol"},{"key":"5544_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11060-017-2635-1","volume":"136","author":"L Gately","year":"2018","unstructured":"Gately L, McLachlan SA, Philip J, Ruben J, Dowling A (2018) Long-term survivors of glioblastoma: a closer look. J Neurooncol 136:155\u2013162. https:\/\/doi.org\/10.1007\/s11060-017-2635-1","journal-title":"J Neurooncol"},{"key":"5544_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/neuros\/nyy049","volume":"84","author":"F Gessler","year":"2019","unstructured":"Gessler F, Bernstock JD, Braczynski A, Lescher S, Baumgarten P, Harter PN, Mittelbronn M, Wu T, Seifert V, Senft C (2019) Surgery for glioblastoma in light of molecular markers: impact of resection and MGMT promoter methylation in newly diagnosed IDH-1 wild-type glioblastomas. Neurosurgery 84:190\u2013197. https:\/\/doi.org\/10.1093\/neuros\/nyy049","journal-title":"Neurosurgery"},{"key":"5544_CR20","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1158\/1078-0432.CCR-13-0017","volume":"19","author":"C Hartmann","year":"2013","unstructured":"Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M, German Glioma N (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 19:5146\u20135157. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0017","journal-title":"Clin Cancer Res"},{"key":"5544_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"5544_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3389\/fonc.2020.01087","volume":"10","author":"F Incekara","year":"2020","unstructured":"Incekara F, Smits M, van der Voort SR, Dubbink HJ, Atmodimedjo PN, Kros JM, Vincent A, van den Bent M (2020) The association between the extent of glioblastoma resection and survival in light of MGMT promoter methylation in 326 patients with newly diagnosed IDH-wildtype glioblastoma. Front Oncol 10:1087. https:\/\/doi.org\/10.3389\/fonc.2020.01087","journal-title":"Front Oncol"},{"key":"5544_CR23","doi-asserted-by":"publisher","first-page":"632663","DOI":"10.3389\/fonc.2021.632663","volume":"11","author":"H Jiang","year":"2021","unstructured":"Jiang H, Yu K, Cui Y, Ren X, Li M, Zhang G, Yang C, Zhao X, Zhu Q, Lin S (2021) Differential predictors and clinical implications associated with long-term survivors in IDH wildtype and mutant glioblastoma. Front Oncol 11:632663. https:\/\/doi.org\/10.3389\/fonc.2021.632663","journal-title":"Front Oncol"},{"key":"5544_CR24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1158\/2159-8290.CD-16-0575","volume":"6","author":"TM Johanns","year":"2016","unstructured":"Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP (2016) Immunogenomics of hypermutated glioblastoma: a patient with germline POLE deficiency treated with checkpoint blockade immunotherapy. Cancer Discov 6:1230\u20131236. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0575","journal-title":"Cancer Discov"},{"key":"5544_CR25","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","volume":"130","author":"D Krex","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G, German Glioma N (2007) Long-term survival with glioblastoma multiforme. Brain 130:2596\u20132606. https:\/\/doi.org\/10.1093\/brain\/awm204","journal-title":"Brain"},{"key":"5544_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"5544_CR27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5544_CR28","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1016\/j.wneu.2021.01.103","volume":"149","author":"VS Madhugiri","year":"2021","unstructured":"Madhugiri VS, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Subeikshanan V, Dutt A, Sasidharan GM, Roopesh Kumar VR, Shankar Ganesh CV, Ramesh AS, Sathia Prabhu A (2021) Analysis of factors associated with long-term survival in patients with glioblastoma. World Neurosurg 149:e758\u2013e765. https:\/\/doi.org\/10.1016\/j.wneu.2021.01.103","journal-title":"World Neurosurg"},{"key":"5544_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clineuro.2014.03.001","volume":"120","author":"P Mazaris","year":"2014","unstructured":"Mazaris P, Hong X, Altshuler D, Schultz L, Poisson LM, Jain R, Mikkelsen T, Rosenblum M, Kalkanis S (2014) Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital. Clin Neurol Neurosurg 120:103\u2013112. https:\/\/doi.org\/10.1016\/j.clineuro.2014.03.001","journal-title":"Clin Neurol Neurosurg"},{"key":"5544_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","volume":"6","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS (2020) Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol 6:495\u2013503. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6143","journal-title":"JAMA Oncol"},{"key":"5544_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.wneu.2017.06.126","volume":"106","author":"Y Nakagawa","year":"2017","unstructured":"Nakagawa Y, Sasaki H, Ohara K, Ezaki T, Toda M, Ohira T, Kawase T, Yoshida K (2017) Clinical and molecular prognostic factors for long-term survival of patients with glioblastomas in single-institutional consecutive cohort. World Neurosurg 106:165\u2013173. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.126","journal-title":"World Neurosurg"},{"key":"5544_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1515\/raon-2015-0041","volume":"50","author":"U Smrdel","year":"2016","unstructured":"Smrdel U, Popovic M, Zwitter M, Bostjancic E, Zupan A, Kovac V, Glavac D, Bokal D, Jerebic J (2016) Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor. Radiol Oncol 50:394\u2013401. https:\/\/doi.org\/10.1515\/raon-2015-0041","journal-title":"Radiol Oncol"},{"key":"5544_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13014-022-01984-w","volume":"17","author":"VN Sommerlath","year":"2022","unstructured":"Sommerlath VN, Buergy D, Etminan N, Brehmer S, Reuss D, Sarria GR, Guiot MC, Hanggi D, Wenz F, Petrecca K, Giordano FA (2022) Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysis. Radiat Oncol 17:15. https:\/\/doi.org\/10.1186\/s13014-022-01984-w","journal-title":"Radiat Oncol"},{"key":"5544_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00701-009-0387-1","volume":"151","author":"Y Sonoda","year":"2009","unstructured":"Sonoda Y, Kumabe T, Watanabe M, Nakazato Y, Inoue T, Kanamori M, Tominaga T (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 151:1349\u20131358. https:\/\/doi.org\/10.1007\/s00701-009-0387-1","journal-title":"Acta Neurochir (Wien)"},{"key":"5544_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Organisation E, for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5544_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Ruda R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"key":"5544_CR37","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/neuonc\/noz011","volume":"21","author":"A Wenger","year":"2019","unstructured":"Wenger A, Ferreyra Vega S, Kling T, Bontell TO, Jakola AS, Caren H (2019) Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Neuro Oncol 21:616\u2013627. https:\/\/doi.org\/10.1093\/neuonc\/noz011","journal-title":"Neuro Oncol"},{"key":"5544_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1212\/WNL.0b013e3182a95680","volume":"81","author":"W Wick","year":"2013","unstructured":"Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M (2013) Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology 81:1515\u20131522. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a95680","journal-title":"Neurology"},{"key":"5544_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","volume":"10","author":"W Wick","year":"2014","unstructured":"Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G (2014) MGMT testing\u2013the challenges for biomarker-based glioma treatment. Nat Rev Neurol 10:372\u2013385. https:\/\/doi.org\/10.1038\/nrneurol.2014.100","journal-title":"Nat Rev Neurol"},{"key":"5544_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-013-1102-x","volume":"113","author":"GB Zhang","year":"2013","unstructured":"Zhang GB, Cui XL, Sui DL, Ren XH, Zhang Z, Wang ZC, Lin S (2013) Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients. J Neurooncol 113:251\u2013258. https:\/\/doi.org\/10.1007\/s11060-013-1102-x","journal-title":"J Neurooncol"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-023-05544-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-023-05544-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-023-05544-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:12:08Z","timestamp":1680502328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-023-05544-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["5544"],"URL":"https:\/\/doi.org\/10.1007\/s00701-023-05544-3","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board \u201cComit\u00e9 d'Ethique Hospitalo-Facultaire Saint-Luc \u2013 UCL\u201d under agreement 2018\/27NOV\/450, in accordance with all applicable laws, regulations, guidelines and approvals, including, without limitation, the Declaration of Helsinki. Given the retrospective nature of the study, specific patient informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}